ERY-TAB
- Product NDC
- 24338-122
- 11-digit product format
- 243380122
- Labeler code
- 24338
- Product ID
- 24338-122_f7f33758-f601-4397-baa4-30286a9a3a39
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Erythromycin
- Dosage form
- TABLET, DELAYED RELEASE
- Route
- ORAL
- Labeler
- Arbor Pharmaceuticals, Inc.
- Application
- ANDA062298
- Marketing category
- ANDA
- Marketing start
- 2011-04-18
- Substance
- ERYTHROMYCIN
- Active strength
- 250 mg/1
- Pharmacologic classes
- Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- ERY-TAB
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ERYTHROMYCIN | 250 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 63937KV33D |
| Rxcui | 206075, 206078, 206080, 310155, 310157, 315090 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 24338-122-03 | ERY-TAB | 30 in 1 BOTTLE | TABLET, DELAYED RELEASE | 30 | | 10 |
| 24338-122-13 | ERY-TAB | 100 in 1 BOTTLE | TABLET, DELAYED RELEASE | 100 | | 10 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| Erythromycin | ACTIVE INGREDIENT | 63937KV33D | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [ARBOR PHARMACEUTICALS, INC.] | 7 | |
| Erythromycin | ACTIVE MOIETY | 63937KV33D | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [ARBOR PHARMACEUTICALS, INC.] | 7 | |
| Ammonia | INACTIVE INGREDIENT | 5138Q19F1X | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [ARBOR PHARMACEUTICALS, INC.] | 7 | |
| cellulose, microcrystalline | INACTIVE INGREDIENT | OP1R32D61U | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [ARBOR PHARMACEUTICALS, INC.] | 7 | |
| croscarmellose sodium | INACTIVE INGREDIENT | M28OL1HH48 | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [ARBOR PHARMACEUTICALS, INC.] | 7 | |
| crospovidone | INACTIVE INGREDIENT | 68401960MK | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [ARBOR PHARMACEUTICALS, INC.] | 7 | |
| diacetylated monoglycerides | INACTIVE INGREDIENT | 5Z17386USF | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [ARBOR PHARMACEUTICALS, INC.] | 7 | |
| hydroxypropyl cellulose (type H) | INACTIVE INGREDIENT | RFW2ET671P | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [ARBOR PHARMACEUTICALS, INC.] | 7 | |
| hypromellose phthalate (24% PHTHALATE, 55 CST) | INACTIVE INGREDIENT | 87Y6436BKR | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [ARBOR PHARMACEUTICALS, INC.] | 7 | |
| hypromelloses | INACTIVE INGREDIENT | 3NXW29V3WO | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [ARBOR PHARMACEUTICALS, INC.] | 7 | |
| magnesium stearate | INACTIVE INGREDIENT | 70097M6I30 | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [ARBOR PHARMACEUTICALS, INC.] | 7 | |
| povidones | INACTIVE INGREDIENT | FZ989GH94E | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [ARBOR PHARMACEUTICALS, INC.] | 7 | |
| propylene glycol | INACTIVE INGREDIENT | 6DC9Q167V3 | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [ARBOR PHARMACEUTICALS, INC.] | 7 | |
| silicon dioxide | INACTIVE INGREDIENT | ETJ7Z6XBU4 | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [ARBOR PHARMACEUTICALS, INC.] | 7 | |
| sodium citrate | INACTIVE INGREDIENT | 1Q73Q2JULR | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [ARBOR PHARMACEUTICALS, INC.] | 7 | |
| sorbitan monooleate | INACTIVE INGREDIENT | 06XEA2VD56 | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [ARBOR PHARMACEUTICALS, INC.] | 7 | |
| talc | INACTIVE INGREDIENT | 7SEV7J4R1U | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [ARBOR PHARMACEUTICALS, INC.] | 7 | |
| titanium dioxide | INACTIVE INGREDIENT | 15FIX9V2JP | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [ARBOR PHARMACEUTICALS, INC.] | 7 | |
| Erythromycin | ACTIVE INGREDIENT | 63937KV33D | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT] | 2 | |
| Erythromycin | ACTIVE MOIETY | 63937KV33D | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT] | 2 | |
| AMMONIA | INACTIVE INGREDIENT | 5138Q19F1X | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT] | 2 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT] | 2 | |
| CROSCARMELLOSE SODIUM | INACTIVE INGREDIENT | M28OL1HH48 | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT] | 2 | |
| CROSPOVIDONE | INACTIVE INGREDIENT | 68401960MK | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT] | 2 | |
| DIACETYLATED MONOGLYCERIDES | INACTIVE INGREDIENT | 5Z17386USF | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT] | 2 | |
| HYDROXYPROPYL CELLULOSE (TYPE H) | INACTIVE INGREDIENT | RFW2ET671P | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT] | 2 | |
| HYPROMELLOSE PHTHALATE (24% PHTHALATE, 55 CST) | INACTIVE INGREDIENT | 87Y6436BKR | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT] | 2 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT] | 2 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT] | 2 | |
| POVIDONES | INACTIVE INGREDIENT | FZ989GH94E | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT] | 2 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT] | 2 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT] | 2 | |
| SODIUM CITRATE | INACTIVE INGREDIENT | 1Q73Q2JULR | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT] | 2 | |
| SORBITAN MONOOLEATE | INACTIVE INGREDIENT | 06XEA2VD56 | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT] | 2 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT] | 2 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT] | 2 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 24338-122 | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [ARBOR PHARMACEUTICALS, INC.] | 10 | Current NDC, Legacy NDC, 2 package rows | 20181212_fda44eb6-7901-4b80-ba0b-216f6cacf3fd.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 24338-122-03 | 24338012203 | 30 TABLET, DELAYED RELEASE in 1 BOTTLE (24338-122-03) | 2017-11-17 | 0000-00-00 | No | No | Current |
| 24338-122-13 | 24338012213 | 100 TABLET, DELAYED RELEASE in 1 BOTTLE (24338-122-13) | 2011-04-18 | 0000-00-00 | No | No | Current |